Luc Xerri

Luc Xerri

UNVERIFIED PROFILE

Are you Luc Xerri?   Register this Author

Register author
Luc Xerri

Luc Xerri

Publications by authors named "Luc Xerri"

Are you Luc Xerri?   Register this Author

89Publications

2768Reads

44Profile Views

[New entities and new tools in hematopathology as proposed by the 2016 WHO classification: Case 5].

Authors:
Luc Xerri

Ann Pathol 2019 Sep 8;39(5):327-330. Epub 2019 Aug 8.

Département de bio-pathologie, Institut Paoli Calmettes, AMU, 282, boulevard Sainte-Marguerite, 13273 Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2019.07.002DOI Listing
September 2019

[New entities and new tools in hematopathology as proposed by the 2016 WHO classification: Case 8].

Authors:
Luc Xerri

Ann Pathol 2019 Sep 12;39(5):339-343. Epub 2019 Aug 12.

Département de bio-pathologie, institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2019.05.007DOI Listing
September 2019

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

N Engl J Med 2018 09;379(10):934-947

From Université Lille, Centre Hospitalier Universitaire (CHU), Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille (F.M.), CHU Régional de Nancy, Service d'Hématologie, Vandoeuvre lès Nancy (P.F.), Institut Paoli-Calmettes (R.B.) and Department of Pathology, Institut Paoli-Calmettes, Centre de Recherche en Cancerologie de Marseille, INSERM, Centre National de la Recherche Scientifique, Aix-Marseille Université (L.X.), Marseille, Centre Henri Becquerel, Unité 1245 and Département d'Hématologie, Université de Rouen, Rouen (H.T.), Institut d'Hématologie de Basse Normandie, Caen (C.F.), CHU Le Bocage Service d'Hématologie Clinique, Dijon (R.-O.C.), Hôpital Henri Mondor Unité Hémopathies Lymphoïdes, Créteil (C.H.), Centre Hospitalier Départemental Vendée Service d'Onco-Hématologie, La Roche sur Yon (H.M.), Institut Universitaire du Cancer de Toulouse Oncopole Service d'Hématologie, Toulouse (L.Y.), CHU Bordeaux, Service d'Hématologie, Bordeaux (K.B.), Hôpital Saint Louis Service d'Onco-Hématologie, Paris (P.B.), Gustave Roussy Cancer, Villejuif (V.R.), Centre Hospitalier Annecy Genevois Service, Annecy (N.D.), CHU de Nantes-Hôtel Dieu Service d'Hématologie Clinique, Centre de Recherche en Cancerologie et Immunologie, INSERM, Centre National de la Recherche Scientifique, Université de Nantes, Nantes (S.L.G.), Centre Hospitalier Métropole Savoie Service Hématologie, Chambery (G.M.P.), Department of Hematology, CHU Montpellier, University of Montpellier, Montpellier (G.C.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, University of Lyon, Pierre-Benite (G.A.S.) - all in France; the Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (N.H.F.); the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (M.L.P.); the Department of Medicine, Division of Medical Oncology, University of Washington, Seattle (E.N.L.); Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.W.F.); Washington University School of Medicine, Siteman Cancer Center, St. Louis (N.L.B.); the Department of Hematology, Hospital Universitario de Salamanca and Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Salamanca (A.M.G.-S.), and the Department of Hematology, Hospital Clinic de Barcelona, Barcelona (A.L.-G.) - both in Spain; CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec (J.-F.L.), and British Columbia Cancer Centre for Lymphoid Cancer, University of British Columbia, Vancouver (L.H.S.) - both in Canada; the Department of Hematology and Oncology, Tokai University Hospital, Kanagawa, Japan (K.A.); Instituto Português de Oncologia Lisboa Francisco Gentil Departamento de Hematologia, Lisbon (M.G.S.); the Department of Hematology, CHU Université Catholique de Louvain Namur, Yvoir (M.A.), and the Department of Hematology, Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp (P.Z.) - both in Belgium; the Department of Hematology, National Cancer Center Hospital, Tokyo, Japan (K.T.); and Celgene, Summit, NJ (D.L., J.W.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805104
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805104DOI Listing
September 2018

Tumor-infiltrating T lymphocytes and morphogenesis of follicular lymphoma-reply.

Hum Pathol 2018 02 8;72:198-199. Epub 2017 Nov 8.

INSERM1052, CNRS 5286, Centre de Recherche en Cancerologie de Lyon, Faculté de Médecine Lyon-Sud Charles Mérieux, Hospices Civils De Lyon, Laboratoire d'hématologie, 69495 Pierre Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.09.018DOI Listing
February 2018

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

J Clin Oncol 2017 Jun 1;35(18):2008-2017. Epub 2017 May 1.

Camille Laurent, Nadia Amara, Georges Delsol, and Pierre Brousset, Institut Universitaire du Cancer-Oncopole de Toulouse; Centre Hospitalier Universitaire (CHU) Toulouse; Camille Laurent, Georges Delsol, and Pierre Brousset, Institut National de la Santé et de la Recherche Médicale (INSERM), U.1037, Centre de Recherche en Cancerologie de Toulouse-Purpan, Laboratoire d'Excellence Toulouse Cancer; Thomas Filleron, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse, Toulouse; Marine Baron, Corinne Haioun, Christiane Copie-Bergman, and Philippe Gaulard, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier; Corinne Haioun, Christiane Copie-Bergman, and Philippe Gaulard, INSERM U955, Université Paris-Est, Créteil; Mylène Dandoit, Marc Maynadié, and Laurent Martin, CHU de Dijon, Dijon; Marie Parrens, Beatrice Vergier, and Antoine de Mascarel, Hôpital du Haut Lévêque, CHU de Bordeaux, Bordeaux; Bettina Fabiani, AP-HP, Hôpital Saint-Antoine; Nicole Brousse and Thierry Jo Molina, AP-HP, Hôpital Necker; Josette Brière, AP-HP, Hôpital Saint Louis; Fréderic Charlotte, AP-HP, Hôpital Pitié Salpétrière; Diane Damotte, AP-HP, Hôpitaux Universitaires Paris Centre, Paris; Alexandra Traverse-Glehen and Françoise Berger, CHU Lyon-Sud; Catherine Chassagne-Clement, Centre Léon Bérard, Lyon; Marie-Christine Copin, Univ Lille, CHU Lille, Lille; Patrick Tas, CHU de Rennes, Rennes; Marie-Christine Rousselet, CHU d'Angers, Angers; Thérèse Rousset, Hôpital Gui de Chauliac, CHU de Montpellier, Montpellier; Luc Xerri, Aix-Marseille Univ, Institut Paoli-Calmettes, Marseille; Anne Moreau and Céline Bossard, Hôpital Hôtel Dieu, CHU de Nantes, Nantes; Antoine Martin, Hôpital Avicenne, Bobigny, Bobigny; Peggy Dartigues, Institut Gustave Roussy, Villejuif; Isabelle Soubeyran, Institut Bergonié, Bordeaux; Michel Peoch, CHU de Saint Etienne, Saint Etienne; Pierre Dechelotte, CHU de Clermont-Ferrand, Clermont-Ferrand; Jean-François Michiels, CHU de Nice, Nice; Flavie Arbion, CHU de Tours, Tours; Isabelle Quintin-Roué, CHU de Brest, Brest; Jean-Michel Picquenot, Centre Henri Becquerel, CHU de Rouen, Rouen; Martine Patey, CHU de Reims, Reims; Blandine Fabre, CHU de Grenoble, Grenoble; Henri Sevestre, CHU d'Amiens, Amiens; Cécile Le Naoures, CHU de Caen, Caen; Marie-Pierre Chenard-Neu, CHU de Strasbourg, Strasbourg; Claire Bastien, CHU de Nancy, Nancy; Sylvie Thiebault, CH de Mulhouse, Mulhouse; Manuela Delage, CHU de Limoges, Limoges; Gilles Salles, Hospices Civils de Lyon, CHU Lyon-Sud; Gilles Salles, INSERM1052, Centre National de la Recherche Scientifique 5286, Université Claude Bernard, Pierre Bénite, France; Tony Petrella, Pathology University of Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2083DOI Listing
June 2017

Marseillevirus in lymphoma: a giant in the lymph node.

Lancet Infect Dis 2016 Oct 5;16(10):e225-e234. Epub 2016 Aug 5.

Research Unit on Emerging Infectious and Tropical Diseases (URMITE), CNRS UMR 7278, IRD 198, Inserm U1095, Aix-Marseille Université, Marseille, France; Méditerranée Infection Foundation (IHU), Assistance Publique-Hôpitaux de Marseille, Marseille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(16)30051-2DOI Listing
October 2016

Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.

Cancer Res 2016 08 31;76(16):4648-60. Epub 2016 May 31.

Centre de recherche en Cancérologie de Marseille, Inserm U1068/CNRS U7258, Marseille, France. Aix Marseille Université, Marseille, France. Institut Paoli - Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0589DOI Listing
August 2016

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

J Clin Oncol 2016 08 13;34(22):2575-82. Epub 2016 Jun 13.

Clémentine Sarkozy and Gilles Salles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie, Pierre Bénite and Université Claude Bernard, Faculté de Médecine Lyon-Sud Charles Mérieux Pierre Bénite; Luc Xerri, Aix-Marseille University and Institut Paoli-Calmettes, Marseille; Pierre Feugier, Centre Hospitalier Universitaire de Nancy and INSERM 954 Université de Lorraine, Nancy; Pauline Brice, Hôpital Saint Louis APHP and Université Paris VII; Danielle Canioni, Assistance Publique Hôpitaux de Paris (APHP) Hôpital Universitaire Necker-Enfants Malades; Richard Delarue, APHP Hôpital Universitaire Necker-Enfants Malades and Descartes-Sorbonne Paris Cité University, Paris; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux, Bordeaux; Christiane Mounier, Institut de Cancérologie Lucien Neuwirth, Saint Priest; Jehan Dupuis, Henri Mondor University Hospital, Créteil; Hervé Tilly, Université de Rouen, Rouen, France; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Nick Wickham, University of Adelaide, Adelaide; Marlton Paula, Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane; John Seymour, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia; Sirpa Leppa, Helsinki University Hospital Cancer Center and University of Helsinki, Helsinki, Finland; Maria Gomes Da Silva, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal; Fritz Offner, Gent University, Gent; Pierre Zachee, ZNA Stuivenberg, Antwerp, Belgium; and Dolores Caballero, Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7163DOI Listing
August 2016

Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Virchows Arch 2016 Mar 23;468(3):245-57. Epub 2015 Aug 23.

Hospital Clinic, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-015-1840-6DOI Listing
March 2016

Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.

Virchows Arch 2016 Feb 28;468(2):141-57. Epub 2015 Sep 28.

Department of Pathology, Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-015-1855-zDOI Listing
February 2016

The heterogeneity of follicular lymphomas: from early development to transformation.

Virchows Arch 2016 Feb 19;468(2):127-39. Epub 2015 Oct 19.

Department of Clinical Pathology, Robert-Bosch-Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-015-1864-yDOI Listing
February 2016

B-cell non-Hodgkin lymphoma linked to Coxiella burnetii.

Blood 2016 Jan 13;127(1):113-21. Epub 2015 Oct 13.

Aix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, Faculté de Médecine, Unité Mixte (UM) 63, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7278, Institut de Recherche Pour le Développement (IRD) 198, INSERM, U1095, Marseille, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-639617DOI Listing
January 2016

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

J Clin Oncol 2015 May 30;33(13):1482-90. Epub 2015 Mar 30.

Jennifer L. Kelly and Jonathan W. Friedberg, James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard Lyon-1, Pierre Benite; Pauline Brice, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris; Olivier Casasnovas, Centre Hospitalo-Universitaire de Dijon, Dijon; Pierre Soubeyran, Institut Bergonié and Université Victor Segalen Bordeaux 2, Bordeaux; Corinne Haioun, Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Créteil; Luc Xerri, Institut Paoli Calmettes, Marseille; Hervé Tilly, Centre Henri Becquerel, Rouen, France; Bryan Goldman, Oliver Press, and Michael LeBlanc, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Richard I. Fisher, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA; and Lisa Rimsza, University of Arizona, Tucson, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/03/30/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.5092
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.5092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404425PMC
May 2015

Constitutive AKT activation in follicular lymphoma.

BMC Cancer 2014 Aug 5;14:565. Epub 2014 Aug 5.

Inserm, U1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131060PMC
August 2014

Nectin-3 (CD113) interacts with Nectin-2 (CD112) to promote lymphocyte transendothelial migration.

PLoS One 2013 7;8(10):e77424. Epub 2013 Oct 7.

Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Univ, Marseille, France ; Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0077424PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792040PMC
June 2014

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

Cancer Res 2013 Dec 18;73(24):7290-300. Epub 2013 Oct 18.

Authors' Affiliations: INSERM, U1068, CRCM, Molecular Oncology, Institut Paoli-Calmettes, Biopathology, Aix-Marseille Univ, UM 105, F-13284, Départements d'Oncologie Médicale, Chirugie oncologique, and Radiologie, Institut Paoli-Calmettes, Marseille; and Plateforme ARN interference PArI, CEA SACLAY, Gif-sur-Yvette, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4704DOI Listing
December 2013

The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.

Blood 2013 Aug 21;122(6):922-31. Epub 2013 May 21.

Institut National de la Santé et de la Recherche Scientifique, U1068, Centre de Recherche en Cancérologie de Marseille-Immunity & Cancer, 27 Bd Lei Roure, Marseille, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/early/2013/05/21/blood-2
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-11-46
Publisher Site
http://dx.doi.org/10.1182/blood-2012-11-464685DOI Listing
August 2013

PD-1 is a novel regulator of human B-cell activation.

Int Immunol 2013 Feb 18;25(2):129-37. Epub 2012 Oct 18.

Inserm U1068, Centre de Recherche en Cancerologie de Marseille, F-13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxs098DOI Listing
February 2013

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

Blood 2012 Feb 3;119(8):1901-3. Epub 2012 Jan 3.

Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-11-391748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293643PMC
February 2012

[The role of co-inhibitory signals driven by CTLA-4 in immune system].

Med Sci (Paris) 2011 Oct 21;27(10):842-9. Epub 2011 Oct 21.

Inserm U891, Centre de recherche en cancérologie de Marseille, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20112710012DOI Listing
October 2011

Gene Expression Profiling for In Silico Microdissection of Hodgkin's Lymphoma Microenvironment and Identification of Prognostic Features.

Adv Hematol 2011 13;2011:485310. Epub 2010 Dec 13.

Department of Bio-Pathology, Institut Paoli-Calmettes, 232, bd Sainte-Marguerite, 13273 Marseille Cedex 09, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/485310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004394PMC
July 2011

[A renal tumour with eosinophilic cells].

Ann Pathol 2010 Oct 16;30(5):406-8. Epub 2010 Oct 16.

Service de biopathologie, institut Paoli-Calmettes, 232, boulevard Sainte Marguerite, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2010.07.003DOI Listing
October 2010

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.

Breast Cancer Res 2009 30;11(2):R23. Epub 2009 Apr 30.

Département d'Oncologie Moléculaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, UMR891 Inserm, IFR137, 232 Bd sainte Marguerite Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688952PMC
August 2009

[Stem cells and epithelial cancers: the example of breast cancer].

Ann Pathol 2008 Nov 17;28 Spec No 1(1):S30-2. Epub 2008 Oct 17.

UMR891, centre de recherche en cancérologie de Marseille, institut Paoli-Calmettes, université de la Méditerranée, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2008.09.005DOI Listing
November 2008

Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

Hum Pathol 2008 Jul 13;39(7):1050-8. Epub 2008 May 13.

Department of Bio-pathology, Institut Paoli-Calmettes, Marseille 13009, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2007.11.012DOI Listing
July 2008

[Misleading signet-ring cells...].

Ann Pathol 2008 Apr 2;28(2):166-8. Epub 2008 Jul 2.

Service d'anatomie et cytologie pathologiques, département de biopathologie, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13273 Marseille cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2007.09.002DOI Listing
April 2008

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

J Clin Oncol 2008 Jan 17;26(3):440-6. Epub 2007 Dec 17.

Department of Pathology, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants Malades, Université Paris-Descartes, 149 rue de Sèvres, 75015, Paris, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.12.8298
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.12.8298DOI Listing
January 2008

Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

Anticancer Res 2007 Sep-Oct;27(5A):3441-9

Departments of Medical Oncology, UMR599 INSERM, Institut Paoli Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
November 2007

Moesin expression is a marker of basal breast carcinomas.

Int J Cancer 2007 Oct;121(8):1779-85

Laboratory of Molecular Oncology, Marseille Cancer Research Institute, UMR599 Inserm/Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22923DOI Listing
October 2007

Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.

Breast 2007 Aug 13;16(4):352-8. Epub 2007 Mar 13.

Institut de Cancérologie de Marseille, Département d'Oncologie Moléculaire, Institut Paoli-Calmettes et UMR599 Inserm, IFR137 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2007.01.002DOI Listing
August 2007

FGFR1 and WT1 are markers of human prostate cancer progression.

BMC Cancer 2006 Nov 30;6:272. Epub 2006 Nov 30.

Centre de Recherche en Cancérologie de Marseille, Département d'Oncologie Moléculaire, UMR599 Inserm et Institut Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-6-272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698935PMC
November 2006

Prognosis and gene expression profiling of 20q13-amplified breast cancers.

Clin Cancer Res 2006 Aug;12(15):4533-44

Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR599 Inserm, Marseilles, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2339DOI Listing
August 2006

[The consortium of Biological Resource Centres (BRC) and tumour cell and tissue banks in the Marseilles metropolitan area].

Med Sci (Paris) 2006 Jan;22 Spec No 1:26-31

Réseau des Centres de Ressources Biologiques et Tumorothèques de l'Agglomération Marseillaise, Biothèque/Tumorothèque/, Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer, Provence-Alpes-Côte d'Azur, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2006221s26DOI Listing
January 2006

Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.

Int J Oncol 2005 Jun;26(6):1485-92

Department of Molecular Oncology, Marseille Cancer Institute, UMR599 Inserm and Paoli-Calmettes Institute, Marseille, France.

View Article

Download full-text PDF

Source
June 2005

[A tumor-like lymphocytis mastitis].

Ann Pathol 2005 Jun;25(3):231-4

Service d'Anatomie et Cytologie Pathologiques du Pr Colette Taranger-Charpin, CHU Nord, Chemin des Bourelly, 13915 Marseille Cedex 20.

View Article

Download full-text PDF

Source
June 2005

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Cancer Res 2005 Mar;65(6):2170-8

Institut de Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 Institut National de la Santé et de la Recherche Médicale, IFR137, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-4115DOI Listing
March 2005

[Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin].

Ann Pathol 2005 Feb;25(1):45-9

Service d'Anatomie et Cytologie Pathologiques, CHU Nord, Bd Pierre Dramard, 13916 Marseille 20.

View Article

Download full-text PDF

Source
February 2005

Gene expression profiling in anaplastic large cell lymphoma and Hodgkin's disease.

Leuk Lymphoma 2004 Oct;45(10):2001-6

INSERM U563 Centre de Physiopathologie de Toulouse-Purpan, IFR31, Purpan Hospital, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190410001713189DOI Listing
October 2004

DNAM-1 and PVR regulate monocyte migration through endothelial junctions.

J Exp Med 2004 May 10;199(10):1331-41. Epub 2004 May 10.

Institut National de la Santé et de la Recherche Médicale UMR599, Institut de Cancérologie de Marseille, IFR 137, 27 Bd. Lei-Roure, 13009 Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20032206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211807PMC
May 2004

LAT regulates gammadelta T cell homeostasis and differentiation.

Nat Immunol 2003 Oct 14;4(10):999-1008. Epub 2003 Sep 14.

Centre d'Immunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale-Centre National de la Recherche Scientifique-Université de la Méditerranée, Parc Scientifique de Luminy, Case 906, 13288 Marseille Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni977DOI Listing
October 2003

Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma.

Int J Oncol 2003 Jul;23(1):97-103

Department of Pathology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, BP 156, F-13273 Marseille cedex 9, France.

View Article

Download full-text PDF

Source
July 2003

Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy.

Int J Exp Pathol 2003 Apr;84(2):75-81

INSERM U119, Service d'Anatomie et Cytologie Pathologiques, Laboratoire d'Immunologie des Tumeurs, Institut Paoli-Calmettes, IFR 57 and Université de la Méditerranée, Marseille, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517548PMC
http://dx.doi.org/10.1046/j.1365-2613.2003.00339.xDOI Listing
April 2003

[Prognostic value of gene expression profiling using cDNA arrays in lymphomas].

Bull Cancer 2002 Jul-Aug;89(7-8):661-5

Département d'oncologie médicale, Institut Paoli-Calmettes, IFR57, 232, boulevard de Sainte-Marguerite, 13273 Marseille, France.

View Article

Download full-text PDF

Source
October 2002

Gene expression profiling defines molecular subtypes of classical Hodgkin's disease.

Oncogene 2002 May;21(19):3095-102

Department of Pathology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, BP 156, 13273 Marseille Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205418DOI Listing
May 2002